Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Note 14 - Capital and Other Components of Equity (Tables)

v3.19.2
Note 14 - Capital and Other Components of Equity (Tables)
12 Months Ended
Mar. 31, 2019
Statement Line Items [Line Items]  
Disclosure of convertible debentures [text block]
 
Accrued interest as at
 
 
Share issuance date
 
 
Number of shares
   
Amount
$
 
                 
March 31, 2017  
April 7, 2017
   
9,496
     
17
 
June 30, 2017  
August 15, 2017
   
23,885
     
40
 
September 30, 2017  
December 27, 2017
   
22,783
     
40
 
December 31, 2017  
March 27, 2018
   
33,605
     
40
 
March 31, 2018  
June 6, 2018
   
30,348
     
40
 
June 30, 2018  
August 21, 2018
   
51,807
     
40
 
September 30, 2018  
October 31, 2018
   
23,723
     
40
 
   
 
   
195,647
     
257
 
Class of warrant or right outstanding [text block]
 
 
March 31, 2019
 
 
March 31, 2018
 
 
March 31, 2017
 
 
February 28, 2017
(Unaudited)
 
 
 
Number
outstanding
 
 
 
Amount
 
 
Number
outstanding
 
 
 
Amount
 
 
Number
outstanding
 
 
 
Amount
 
 
Number
outstanding
 
 
 
Amount
 
 
 
 
 
 
$
 
 
 
 
 
$
 
 
 
 
 
$
 
 
 
 
 
$
 
Liability
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
May 2018 Public offering Warrants 2018 (i)
 
 
10,188,100
 
 
 
8,246
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
Series December 2017 US Public offering Warrants 2017 (ii)
 
 
9,801,861
 
 
 
8,017
 
 
 
9,802,935
 
 
 
6,405
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
Series 8 Public offering Warrants December 2013 (iii)
 
 
-
 
 
 
-
 
 
 
18,400,000
 
 
 
21
 
 
 
18,400,000
 
 
 
209
 
 
 
18,400,000
 
 
 
187
 
 
 
 
19,989,961
 
 
 
16,263
 
 
 
28,202,935
 
 
 
6,426
 
 
 
18,400,000
 
 
 
209
 
 
 
18,400,000
 
 
 
187
 
Equity
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Public offering warrants
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Public offering broker warrants May 2018 (iv)
 
 
547,975
 
 
 
283
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
Public offering U.S. broker warrants December 2017 (v)
 
 
495,050
 
 
 
406
 
 
 
495,050
 
 
 
406
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
Public offering warrants February 2017 (vi)
 
 
1,904,034
 
 
 
-
 
 
 
1,904,034
 
 
 
-
 
 
 
1,965,259
 
 
 
-
 
 
 
1,965,259
 
 
 
-
 
Private Placement- contingent warrants
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2017 unsecured convertible debenture conversion option and contingent warrants (vii)
 
 
1,052,630
 
 
 
309
 
 
 
1,052,630
 
 
 
309
 
 
 
1,052,630
 
 
 
309
 
 
 
1,052,630
 
 
 
309
 
Series 9 Private Placement warrants 2013 (viii)
 
 
-
 
 
 
-
 
 
 
161,654
 
 
 
-
 
 
 
161,654
 
 
 
-
 
 
 
161,654
 
 
 
-
 
Series 2017 BW Broker warrants (ix)
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
234,992
 
 
 
144
 
 
 
234,992
 
 
 
144
 
 
 
 
3,999,689
 
 
 
998
 
 
 
3,613,368
 
 
 
715
 
 
 
3,414,535
 
 
 
453
 
 
 
3,414,535
 
 
 
453
 
Warrants [member]  
Statement Line Items [Line Items]  
Disclosure of sensitivity analysis for actuarial assumptions [text block]
    May 2018  
Exercise price   $
1.31
 
Share price   $
0.82
 
Risk-free interest    
2.21
%
Estimated life (in years)    
5
 
Expected volatility    
87.40
%
    May 2018  
Exercise price   $
1.05
 
Share price   $
0.81
 
Risk-free interest    
2.20
%
Estimated life (in years)    
5
 
Expected volatility    
87.40
%
    December 27,
2017
 
Exercise price    
US $1.26
 
Share price    
US $0.97
 
Risk-free interest    
2.22
%
Estimated life (in years)    
5
 
Expected volatility    
93.52
%
    December 27,
2017
 
Exercise price    
US $1.2625
 
Share price    
US $0.97
 
Risk-free interest    
2.22
%
Estimated life (in years)    
5
 
Expected volatility    
93.52
%
    February 21, 2017  
       
Exercise price   $
2.15
 
Share price   $
1.70
 
Dividend    
-
 
Risk-free interest    
0.79
%
Estimated life (in years)    
1.00
 
Expected volatility    
112.09
%